Cite
HARVARD Citation
Kvorning Ternov, K. et al. (2019). Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer (HEAT): a randomised trial protocol. BMJ open. 9 (9), p. . [Online].